相关实验视频

Updated: Jan 17, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

血清尿酸与冠状动脉CT血管学评估的高风险斑块之间的关联

Xinguang Long¹, Yao Jing², Zhou Haitao³

¹Cardiology, Yangzhongshi renmin yiyuan, Zhenjiang, Jiangsu, China c0926262@163.com.

|September 24, 2025

概括

血清尿酸 (UA) 是通过冠状动脉CT血管造影 (CCTA) 检测到的高风险冠状动脉斑块的独立风险因素. 测量UA可以改善冠状动脉疾病 (CAD) 的检测和风险分层.

科学领域:

心血管成像 - 心血管成像
生物标志物生物标志物
动脉样硬化研究动脉样硬化研究

背景情况:

冠状动脉CT血管造影 (CCTA) 上的高风险斑块 (HRPs) 是急性冠状动脉事件的关键指标.
血清尿酸 (UA) 已与心血管疾病有关,但其与HRPs的特定关联需要进一步调查.

研究的目的:

确定血清尿酸水平与CCTA识别的高风险冠状动脉斑块存在之间的关联.
评估血清UA对HRPs的独立预测值.

主要方法:

对接受CCTA的1411名门诊患者进行了回顾性分析.
HRPs是由特定的斑块特征定义的 (积极的重塑,低衰减斑块,餐巾环标志,斑点化).
使用后勤回归和ROC曲线分析来评估血清UA和HRP风险之间的关系,并进行子组分析.

主要成果:

血清尿酸在多变量调整后独立地与更高的HRPs风险相关 (OR2.96每SD增量,p<0.001).
结合血清UA的预测模型表现出很好的准确性 (AUC 0.86).
在基于性别,糖尿病,吸烟,饮酒或阻塞性CAD的子组分析中没有观察到显著的效果修改.

结论:

血清尿酸是CCTA上存在高风险冠状动脉斑块的独立风险因素.
当与临床因素相结合时,血清UA测量可能会提高冠状动脉疾病的诊断和预后能力.

关键词:

动脉样硬化是一种动脉样硬化.生物标志物生物标志物计算机断层扫描血管学冠状动脉血管冠状动脉血管诊断成像诊断成像诊断成像

更多相关视频

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

相关概念视频

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Imaging Studies for Cardiovascular System V: CT

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...